JP5846384B2 - カワハギ由来の細胞株 - Google Patents
カワハギ由来の細胞株 Download PDFInfo
- Publication number
- JP5846384B2 JP5846384B2 JP2012169378A JP2012169378A JP5846384B2 JP 5846384 B2 JP5846384 B2 JP 5846384B2 JP 2012169378 A JP2012169378 A JP 2012169378A JP 2012169378 A JP2012169378 A JP 2012169378A JP 5846384 B2 JP5846384 B2 JP 5846384B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- cell line
- fish
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004027 cell Anatomy 0.000 claims description 611
- 108090000623 proteins and genes Proteins 0.000 claims description 80
- 238000000034 method Methods 0.000 claims description 77
- 241000251468 Actinopterygii Species 0.000 claims description 62
- 239000002609 medium Substances 0.000 claims description 60
- 235000019688 fish Nutrition 0.000 claims description 57
- 210000002966 serum Anatomy 0.000 claims description 56
- 210000004748 cultured cell Anatomy 0.000 claims description 36
- 238000004519 manufacturing process Methods 0.000 claims description 30
- 230000014509 gene expression Effects 0.000 claims description 26
- 210000000349 chromosome Anatomy 0.000 claims description 20
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims description 16
- 210000004962 mammalian cell Anatomy 0.000 claims description 15
- 102000016289 Cell Adhesion Molecules Human genes 0.000 claims description 13
- 239000002771 cell marker Substances 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 12
- 239000013598 vector Substances 0.000 claims description 12
- 239000006143 cell culture medium Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 238000009826 distribution Methods 0.000 claims description 8
- 210000004185 liver Anatomy 0.000 claims description 8
- 210000001217 buttock Anatomy 0.000 claims description 7
- 210000002919 epithelial cell Anatomy 0.000 claims description 7
- 210000002569 neuron Anatomy 0.000 claims description 7
- 238000001890 transfection Methods 0.000 claims description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 6
- 241000238631 Hexapoda Species 0.000 claims description 6
- 241001282117 Stephanolepis cirrhifer Species 0.000 claims description 6
- 210000001789 adipocyte Anatomy 0.000 claims description 6
- 241001282115 Monacanthidae Species 0.000 claims description 5
- 241000287462 Phalacrocorax carbo Species 0.000 claims description 4
- 210000001015 abdomen Anatomy 0.000 claims description 4
- 210000000038 chest Anatomy 0.000 claims description 4
- 230000001747 exhibiting effect Effects 0.000 claims description 4
- 210000002865 immune cell Anatomy 0.000 claims description 4
- 210000005229 liver cell Anatomy 0.000 claims description 4
- 210000000663 muscle cell Anatomy 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 241000907205 Aluterus Species 0.000 claims description 3
- 241000907185 Cantherhines Species 0.000 claims description 2
- 241000859632 Rudarius Species 0.000 claims description 2
- 241001282118 Stephanolepis Species 0.000 claims description 2
- 241001676703 Thamnaconus Species 0.000 claims description 2
- 238000010186 staining Methods 0.000 claims description 2
- 102000008395 cell adhesion mediator activity proteins Human genes 0.000 claims 3
- 241000972773 Aulopiformes Species 0.000 claims 1
- 235000014653 Carica parviflora Nutrition 0.000 claims 1
- 241000243321 Cnidaria Species 0.000 claims 1
- 241001529466 Muscardinus avellanarius Species 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 235000019515 salmon Nutrition 0.000 claims 1
- 230000002463 transducing effect Effects 0.000 claims 1
- 239000000047 product Substances 0.000 description 30
- 239000000126 substance Substances 0.000 description 19
- 230000004069 differentiation Effects 0.000 description 18
- 239000012091 fetal bovine serum Substances 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 14
- 241000700605 Viruses Species 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 238000010586 diagram Methods 0.000 description 12
- 239000010410 layer Substances 0.000 description 12
- 210000001778 pluripotent stem cell Anatomy 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 239000000654 additive Substances 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 6
- 230000003698 anagen phase Effects 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 230000002062 proliferating effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 5
- NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 102000006996 Aryldialkylphosphatase Human genes 0.000 description 4
- 108010008184 Aryldialkylphosphatase Proteins 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 208000036142 Viral infection Diseases 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000834 fixative Substances 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000000815 hypotonic solution Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 210000000107 myocyte Anatomy 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 230000009385 viral infection Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010067306 Fibronectins Proteins 0.000 description 3
- 102000016359 Fibronectins Human genes 0.000 description 3
- 241000237858 Gastropoda Species 0.000 description 3
- 101000666657 Homo sapiens Rho-related GTP-binding protein RhoQ Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 102100038339 Rho-related GTP-binding protein RhoQ Human genes 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000013024 dilution buffer Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 108091006047 fluorescent proteins Proteins 0.000 description 3
- 102000034287 fluorescent proteins Human genes 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- 241001504639 Alcedo atthis Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000000584 Calmodulin Human genes 0.000 description 2
- 108010041952 Calmodulin Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 2
- 206010013647 Drowning Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 108010085895 Laminin Proteins 0.000 description 2
- 102000007547 Laminin Human genes 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 241000555745 Sciuridae Species 0.000 description 2
- 241000239226 Scorpiones Species 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 208000010824 fish disease Diseases 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- 238000001638 lipofection Methods 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108010054624 red fluorescent protein Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 238000003151 transfection method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 1
- 241000252335 Acipenser Species 0.000 description 1
- 241000881711 Acipenser sturio Species 0.000 description 1
- 241001450805 Allenbatrachus grunniens Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100028791 Caenorhabditis elegans pbs-5 gene Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 101100137155 Homo sapiens POU5F1 gene Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000486187 Menticirrhus Species 0.000 description 1
- 241001292372 Nemadactylus bergi Species 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108050003896 Protein yellow Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000011186 acute T cell leukemia Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- -1 culture vessel Substances 0.000 description 1
- 108010082025 cyan fluorescent protein Proteins 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010012440 human TRA-1-60 antigen Proteins 0.000 description 1
- 102000019099 human TRA-1-60 antigen Human genes 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229940028444 muse Drugs 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 102000045246 noggin Human genes 0.000 description 1
- 108700007229 noggin Proteins 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000009372 pisciculture Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012169378A JP5846384B2 (ja) | 2012-07-31 | 2012-07-31 | カワハギ由来の細胞株 |
| EP13825193.9A EP2881460B1 (en) | 2012-07-31 | 2013-07-30 | Cell strain derived from monacanthidae |
| US14/418,781 US9777254B2 (en) | 2012-07-31 | 2013-07-30 | Cell line derived from thread-sail filefish (Stephanolepis cirrhifer) |
| PCT/JP2013/070627 WO2014021329A1 (ja) | 2012-07-31 | 2013-07-30 | カワハギ由来の細胞株 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012169378A JP5846384B2 (ja) | 2012-07-31 | 2012-07-31 | カワハギ由来の細胞株 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014027888A JP2014027888A (ja) | 2014-02-13 |
| JP2014027888A5 JP2014027888A5 (enExample) | 2015-07-23 |
| JP5846384B2 true JP5846384B2 (ja) | 2016-01-20 |
Family
ID=50028002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012169378A Expired - Fee Related JP5846384B2 (ja) | 2012-07-31 | 2012-07-31 | カワハギ由来の細胞株 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9777254B2 (enExample) |
| EP (1) | EP2881460B1 (enExample) |
| JP (1) | JP5846384B2 (enExample) |
| WO (1) | WO2014021329A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6756502B2 (ja) * | 2016-03-29 | 2020-09-16 | テルモ株式会社 | 細胞培養物およびその製造方法 |
| CN108893474B (zh) * | 2018-02-07 | 2021-11-16 | 电子科技大学 | 草鱼细胞间粘附分子基因的分离和鉴定 |
| CN113637632A (zh) * | 2021-07-20 | 2021-11-12 | 宁波大学 | 一种银鲳肌肉组织细胞系 |
| CN115595297B (zh) * | 2022-09-22 | 2023-10-13 | 中国水产科学研究院南海水产研究所 | 一种卵形鲳鲹肌肉细胞系及构建方法和应用 |
| CN119979723B (zh) * | 2025-03-13 | 2025-10-03 | 中国水产科学研究院北戴河中心实验站 | 鉴定绿鳍马面鲀性别的特异性dna片段、引物及其应用和鉴定绿鳍马面鲀性别的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4065150B2 (ja) | 2002-06-28 | 2008-03-19 | 株式会社フジキン | チョウザメ由来の新規な株化細胞 |
| US7132230B2 (en) | 2002-06-28 | 2006-11-07 | Fujikin Incorporated | Cytotoxic assay and new established cell line of sturgeon origin |
| JP2008220198A (ja) * | 2007-03-09 | 2008-09-25 | Japan Agengy For Marine-Earth Science & Technology | カサゴ細胞株 |
-
2012
- 2012-07-31 JP JP2012169378A patent/JP5846384B2/ja not_active Expired - Fee Related
-
2013
- 2013-07-30 EP EP13825193.9A patent/EP2881460B1/en not_active Not-in-force
- 2013-07-30 US US14/418,781 patent/US9777254B2/en not_active Expired - Fee Related
- 2013-07-30 WO PCT/JP2013/070627 patent/WO2014021329A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2881460A1 (en) | 2015-06-10 |
| US20150175958A1 (en) | 2015-06-25 |
| EP2881460A4 (en) | 2015-12-30 |
| WO2014021329A1 (ja) | 2014-02-06 |
| EP2881460B1 (en) | 2019-01-02 |
| JP2014027888A (ja) | 2014-02-13 |
| US9777254B2 (en) | 2017-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101582483B1 (ko) | 심근 세포의 세포괴의 제조 방법 및 상기 심근 세포괴의 용도 | |
| Jin et al. | Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling | |
| KR100812856B1 (ko) | 영장류의 배아 줄기 세포로부터 배상체를 제조하는 방법 | |
| KR102254082B1 (ko) | 망막 색소 상피 세포 시트의 제조 방법 | |
| JP5846384B2 (ja) | カワハギ由来の細胞株 | |
| Viesselmann et al. | Nucleofection and primary culture of embryonic mouse hippocampal and cortical neurons | |
| US11801267B2 (en) | Cardiac cell culture material | |
| WO2016127908A1 (zh) | 一种三维复合细胞聚集体模型及其制备方法与应用 | |
| KR20190112090A (ko) | 다능성줄기세포의 분화 제어 방법 | |
| CN111263807A (zh) | 人工脂肪组织及其制造方法、人工皮肤的制造方法以及脂肪细胞的培养试剂 | |
| TW201504435A (zh) | 毛囊形成用組合物之品質管理方法 | |
| Weinstein et al. | Isolation and purification of primary Schwann cells | |
| Dash et al. | Derivation and characterization of embryonic stem‐like cells of Indian major carp Catla catla | |
| KR102241349B1 (ko) | 각막상피세포 집단의 제조 방법 | |
| WO2017150294A1 (ja) | 多能性幹細胞様スフェロイドの製造方法および多能性幹細胞様スフェロイド | |
| EP4605520A1 (en) | Compositions and methods relating to adipocyte production | |
| WO2025063278A1 (ja) | コアシェル構造の三次元構造物 | |
| Elbaghdady et al. | Isolation and Molecular Characterization of Spermatogonial Stem Cells in Nile Tilapia | |
| Abdullah et al. | Differentiation of Mouse Bone-Marrow Mesenchymal Stem Cells into Motor Neuron Cells in vitro. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150603 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150603 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20150603 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20150623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150707 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150904 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151104 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151110 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5846384 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |